Citation Impact
Citing Papers
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Natural history and prognostic factors for chronic hepatitis type B.
1991
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
2009
Management of hepatitis B
2007
T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection
1995
Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B
2006
The Effect of Concurrent Human Immunodeficiency Virus Infection on Chronic Hepatitis B: A Study of 150 Homosexual Men
1989
Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled Trials
2002
Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan
2001
Hepatocellular carcinoma
2003 Standout
Hepatitis C virus: Epidemiology and transmission
1997
Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver
1999
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
2006
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Hepatitis flares and hepatitis B e antigen seroconversion: Implication in anti‐hepatitis B virus therapy1
2003
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
2002 Standout
Atopic dermatitis
2003 Standout
Hepatocellular carcinoma
2018 Standout
Hepatitis C Virus Infection
2001 Standout
Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden
2009
Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog
2012
Predicting absolute risk of CIN3 during post-colposcopic follow-up: Results from the ASCUS-LSIL Triage Study (ALTS)
2006
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
1992
Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients
2006
Epidemiological characteristics and risk factors of hepatocellular carcinoma
1997
Efficacy of thymosin α1 in patients with chronic hepatitis B: A randomized, controlled trial
1998
Multicentre randomised phase III trial comparing Tamoxifen alone or with Transarterial Lipiodol Chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (Fédération Francophone de Cancérologie Digestive 9402)
2008
Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
1999
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
1999 Standout
The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes
2001 StandoutNobel
Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma
2002
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
1988
Analysis of cost‐effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers
1992
Management of hepatitis B: 2000—Summary of a workshop
2001
Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies
2006
Asian‐Pacific consensus statement on the management of chronic hepatitis B: An update*
2003
Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion
2006
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection
2002
Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection☆
2004
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
2003 Standout
Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C
2002
Incidence and Cofactors of Hepatitis C Virus-related Hepatocellular Carcinoma: A Prospective Study of 12,008 Men in Taiwan
2003
HBsAg seroclearance in asymptomatic carriers of high endemic areas
2007
Secular trend of age‐specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan
2003
The clinical significance of persistently normal ALT in chronic hepatitis B infection
2007
Hepatocellular carcinoma
2012 Standout
A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive chinese children
1988
Hepatitis B virus infection
2009 Standout
Plasma Selenium Levels and Risk of Hepatocellular Carcinoma among Men with Chronic Hepatitis Virus Infection
1999
Chronic hepatitis B
2001
Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study
2007
Selenium and human health
2012 Standout
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study
1994
Natural history of chronic HBV infection: A cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project)
2005
Natural History of Chronic Hepatitis B Virus Infection: What We Knew in 1981 and What We Know in 2005
2006
Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?
2015
Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents
2016
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Hepatitis B e antigen-negative chronic hepatitis B
2001
Hepatitis B vaccines
2003
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma
2004
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1
2005
A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy
1989
Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection
1990
Protective Immune Response to Hepatitis C Virus in Chimpanzees Rechallenged Following Clearance of Primary Infection
2001 StandoutNobel
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Management of Hepatocellular Carcinoma *
2005 Standout
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Natural history of hepatitis b e antigen to antibody seroconversion in patients with normal serum aminotransferase levels
2004
Clinical Implications of Alpha-fetoprotein in Chronic Hepatitis C
2009
Global cancer statistics
2011 Standout
Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients
2006
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
The importance of selenium to human health
2000 Standout
Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis
1990
Diabetes in Asia
2009 Standout
Long‐term outcome of chronic hepatitis B based on histological grade and stage
2007
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
2010
Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type B
1995
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
2005
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
2001 Standout
Detection of Type 2–Like T–Helper Cells in Hepatitis C Virus Infection: Implications for Hepatitis C Virus Chronicity
1997
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
1996 Standout
Chemoembolization for hepatocellular carcinoma
2004
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Seropositivity of hepatitis B e antigen and hepatocellular carcinoma
2004
Human papillomavirus and cervical cancer
2007 Standout
Characteristics of patients with dual infection by hepatitis B and C viruses
1998
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
2010
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Chronic hepatitis B
2007 Standout
Lymphoblastoid interferon therapy of chronic HBV infection
1987
Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
2006
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
The natural history of chronic hepatitis B virus infection #
2009
Hepatocellular Carcinoma in Italian Patients with Cirrhosis
1991
Prospective Analysis of Risk Factors for Hepatocellular Carcinoma in Patients With Liver Cirrhosis
2003
Chronic hepatitis B: Update 2009 #
2009 Standout
Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis
1999
Role of viral factors in the natural course and therapy of chronic hepatitis B
2007
Combination therapy with interferon‐α and ribavirin in patients with dual hepatitis B and hepatitis C virus infection
2005
Multicenter Study of Hepatitis C Virus Infection in Chronic Hemodialysis Patients and Hemodialysis Center Staff Members
1993
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
2000
Loco‐regional treatment of hepatocellular carcinoma†
2010
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
2002 Standout
Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
2013 StandoutNobel
Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity
1998
Management of HCC
2012
Resection and Liver Transplantation for Hepatocellular Carcinoma
2005
Predictive Factors for Reactivation of Hepatitis B Following Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B
2007
Long–Term Beneficial Effect of Interferon Therapy in Patients With Chronic Hepatitis B Virus Infection
1999
Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies
2006
The impact of sex, gender and pregnancy on 2009 H1N1 disease
2010
Acute Exacerbation of Chronic Hepatitis B Virus Infection After Withdrawal of Lamivudine Therapy
2000
Clinical course after stopping lamivudine in chronic hepatitis B patients with lamivudine‐resistant mutants
2004
Hepatocellular carcinoma
1991
Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis
1998
A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
1990
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis
2010
Local-Regional Treatment of Hepatocellular Carcinoma
2011
Animal Models for Hepatitis C
2013
Changes of serum hepatitis B virus DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children
1990
The effect of lamivudine therapy in hepatic decompensation during acute exacerbation of chronic hepatitis B
2003
Occult hepatitis B
2002
Increased Incidence of Fulminant Hepatic Failure in Previously Unrecognized HBsAg Carriers with Acute Hepatitis Independent of Etiology
2005
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
2002
Natural history of liver fibrosis progression in patients with chronic hepatitis C
1997 Standout
Asian‐Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
2005
Spontaneous relapse of hepatitis in inactive HBsAg carriers
2007
Medical treatments for hepatocellular carcinoma (HCC): what’s next?
2006
Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: A longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline
2005
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Familial Risk of Hepatocellular Carcinoma Among Chronic Hepatitis B Carriers and Their Relatives
2000
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients
2007
Hepatocellular Carcinoma
2011 Standout
Carriers of Inactive Hepatitis B Virus Are Still at Risk for Hepatocellular Carcinoma and Liver-Related Death
2010
Parvovirus B19
2004 Standout
Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies
2006
Alcohol and Hepatocellular Carcinoma: The Effect of Lifetime Intake and Hepatitis Virus Infections in Men and Women
2002
Prospective Cohort Study of Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma in 8510 Patients
2006
Prevalence of Parvovirus B19 in Liver Tissue: No Association with Fulminant Hepatitis or Hepatitis‐Associated Aplastic Anemia
2003
Hepatocellular carcinoma
2022 Standout
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
2002
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis
2006
Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
2000
2017
Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis
2001
Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults
1987
Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study
1994
Hepatocellular Carcinoma
2019 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus
2001
A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Study in Taiwan
2006
Survival in Chronic Hepatitis B
1984
Natural History of Chronic Hepatitis B Virus Infection in Taiwan: Studies of Hepatitis B Virus Dna in Serum
1985
Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective study
1991
Clinical, Virologic and Histologic Outcome Following Seroconversion From Hbeag to Anti–Hbe in Chronic Hepatitis Type B
1986
Inhibition of Hepatitis B Virus Replication during Adenovirus and Cytomegalovirus Infections in Transgenic Mice
1998
Food allergy. Part 1: Immunopathogenesis and clinical disorders
1999
Precore Stop Mutant in HBeAg-Positive Patients with Chronic Hepatitis B: Clinical Characteristics and Correlation with the Course of HBeAg-to-Anti-HBe Seroconversion
2002
Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis
1987
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
2009
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal
1995
Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data
2016
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
2007
Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection
1987
Hepatitis B Virus Replication and Liver Disease Progression: The Impact of Antiviral Therapy
2006
Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma
2011
Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis
2015
Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: Multistage hepatocarcinogenesis with multifactorial etiology
2002
Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis
2009
Factors influencing liver disease progression in chronic hepatitis B
2006
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Spontaneous reactivation of chronic hepatitis B virus infection
1984
Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection
1998 StandoutNobel
Works of Deng‐Yn Lin being referenced
Acute expression of hepatitis C core protein in adult mouse liver: Mitochondrial stress and apoptosis
2008
Age‐specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in taiwan: A comparison among asymptomatic carriers, Chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
1984
Prospective randomized controlled study of interferon‐alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors
2004
Role of Hepatitis C and Delta Viruses in the Termination of Chronic Hepatitis B Surface Antigen Carrier State: A Multivariate Analysis in a Longitudinal Follow-up Study
1994
Prevalence of Antibodies to Hepatitis C Virus in the Hemodialysis Unit
1991
Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis
1994
Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: A longitudinal study
1993
Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma—A randomized controlled trial
1988
Cytologic Changes in Hepatocellular Carcinoma After Percutaneous Acetic Acid Injection
2000
Etiology of sporadic acute viral hepatitis in Taiwan: The role of hepatitis C virus, hepatitis E virus and GB virus-C/hepatitis G virus in an endemic area of hepatitis A and B
1999
Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study
1989
Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection
1999
Prospective Study of Hepatocellular Carcinoma and Liver Cirrhosis in Asymptomatic Chronic Hepatitis B Virus Carriers
1997
Long‐term outcome of hepatitis B e antigen–negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time†
2009
High Incidence of Hepatitis C Virus Infection in Hemodialysis Patients in Taiwan
1993
Percutaneous local ablation therapy in small hepatocellular carcinoma.
2003
Efficacy and safety of nintedanib versus sorafenib in Asian patients with advanced hepatocellular carcinoma (HCC): A randomized phase II trial.
2015
Determinants for hepatitis B e antigen clearance in chronic type B hepatitis
1984
Clinical and Histological Events Preceding Hepatitis B e Antigen Seroconversion in Chronic Type B Hepatitis
1983
Sex Difference in Chronic Hepatitis B Virus Infection: An Appraisal Based on the Status of Hepatitis B e Antigen and Antibody
1983
Hepatocellular carcinoma in noncirrhotic patients. A laparoscopic study of 92 cases in Taiwan
1984
Impact of gender, viral transmission and aging in the prevalence of hepatitis B surface antigen.
2009
Eosinophilic gastroenteritis: 10 years experience.
1993
Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis
1986
Chronic Lobular Hepatitis: A Clinicopathological and Prognostic Study
1982
The Window Period Between Hepatitis B e Antigen and Antibody in Chronic Type B Hepatitis
1984